Ubs Group Ag Stevanato Group S.P.A. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Ubs Group Ag holds 437,177 shares of STVN stock, worth $9.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

437,177

Previous 456,438 4.22%

Holding current value

$9.71 Million

Previous $9.95 Million 10.24%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$18.11 - $24.11 $348,816 - $464,382	-19,261 Reduced 4.22%	437,177 $8.93 Million
Q4 2024 Feb 14, 2025	BUY	$17.27 - $23.67 $7.01 Million - $9.6 Million	405,762 Added 800.7%	456,438 $9.95 Million
Q3 2024 Nov 14, 2024	BUY	$17.98 - $22.02 $252,798 - $309,601	14,060 Added 38.4%	50,676 $1.01 Million
Q2 2024 Aug 13, 2024	BUY	$16.93 - $31.33 $599,592 - $1.11 Million	35,416 Added 2951.33%	36,616 $671,000
Q1 2024 May 13, 2024	BUY	$25.34 - $34.28 $25,340 - $34,280	1,000 Added 500.0%	1,200 $38,000
Q4 2023 Feb 09, 2024	SELL	$25.21 - $34.66 $59,243 - $81,450	-2,350 Reduced 92.16%	200 $5,000
Q3 2023 Nov 09, 2023	BUY	$26.91 - $35.49 $68,620 - $90,499	2,550 New	2,550 $75,000
Q1 2023 May 12, 2023	BUY	$17.5 - $25.9 $16,502 - $24,423	943 Added 834.51%	1,056 $27,000
Q4 2022 Feb 08, 2023	BUY	$13.95 - $19.28 $1,576 - $2,178	113 New	113 $2,000
Q2 2022 Aug 10, 2022	SELL	$14.1 - $20.26 $25,365 - $36,447	-1,799 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$15.23 - $21.47 $12,168 - $17,154	799 Added 79.9%	1,799 $36,000
Q4 2021 Feb 14, 2022	SELL	$21.65 - $27.0 $25,590 - $31,914	-1,182 Reduced 54.17%	1,000 $22,000
Q3 2021 Nov 15, 2021	BUY	$19.51 - $28.7 $42,570 - $62,623	2,182 New	2,182 $55,000

Others Institutions Holding STVN

# of Institutions

146

Shares Held

53.7M

Call Options Held

Put Options Held

View Full List

About Stevanato Group S.p.A.

Ticker STVN
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 264,700,000
Market Cap $5.88B
Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...

More about STVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account